mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma', 'merck', 'moderna']
moderna and merck plan to launch a phase iii study this year for their personalized cancer vaccine in melanoma, and have revealed more details from a phase iib test that earlier this year renewed excitement about the use of vaccines in fighting tumors. 
Biopharma reporter @endpts | nicole@endpointsnews.com